News Category
Lantern Pharma's Q2 2026 results highlight progress in its AI-driven oncology pipeline, including promising LP-300 trial data and the establishment of...
Lantern Pharma's upcoming Q2 2026 earnings webcast will detail progress on its AI platforms and clinical pipeline, underscoring the company's strategi...
Lantern Pharma received a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for LP-184 therapy, advancing pr...
Formycon AG partners with OneSource Specialty Pharma to leverage cost-efficient manufacturing in India for global biosimilar supply, aiming to enhance...
Lantern Pharma's new ZetaOmics platform introduces an autonomous computational biologist agent that automates complex bioinformatics workflows, expand...
Academy Hunt has expanded its platform to include over 1,000 course comparisons for AI, machine learning, and data science programs in India, helping ...
Quantum Genesis AI Corp. issues a press release to distinguish itself from Quantumzyme LLP and clarify that intellectual property from research by its...
Lantern Pharma closed a $4.4 million registered direct offering, with potential additional proceeds from warrants, to support its precision oncology p...
Lantern Pharma announced the expansion of its predictBBB platform into a Large Quantitative Model, enabling real-time molecular intelligence for drug ...
Lantern Pharma will host its first live demonstration of the withZeta.ai multi-agentic AI platform, highlighting its potential to accelerate oncology ...
